Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -79.49% | 246.67% | -12.12% | 183.06% | 449.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -79.49% | 246.67% | -12.12% | 183.06% | 449.87% |
| Cost of Revenue | -83.38% | 156.74% | 16.76% | 349.06% | 796.49% |
| Gross Profit | -69.57% | 39.89% | -32.10% | 57.24% | 176.92% |
| SG&A Expenses | -60.11% | 218.39% | -4.76% | 90.25% | 208.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -84.45% | 98.11% | 592.42% | 154.92% | 203.16% |
| Total Operating Expenses | -78.14% | 207.52% | 10.54% | 240.90% | 550.81% |
| Operating Income | -98.51% | -68.39% | -78.77% | -9.47% | 72.60% |
| Income Before Tax | -220.45% | -155.07% | -115.49% | 4.30% | 33.96% |
| Income Tax Expenses | -467.43% | -302.05% | -123.21% | -78.34% | -88.27% |
| Earnings from Continuing Operations | -208.40% | -146.55% | -112.83% | 57.63% | 172.64% |
| Earnings from Discontinued Operations | -- | 46.97% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -84.93% | -26.69% | -25.00% |
| Net Income | -174.95% | -120.78% | -52.25% | 241.95% | 641.34% |
| EBIT | -98.51% | -68.39% | -78.77% | -9.47% | 72.60% |
| EBITDA | -93.71% | -83.39% | -68.21% | -23.85% | 19.82% |
| EPS Basic | -170.54% | -118.12% | -57.48% | 193.45% | 495.74% |
| Normalized Basic EPS | -175.65% | -111.95% | -88.13% | -54.68% | -16.10% |
| EPS Diluted | -169.77% | -116.09% | -54.63% | 198.28% | 504.68% |
| Normalized Diluted EPS | -175.65% | -111.95% | -88.13% | -54.68% | -16.10% |
| Average Basic Shares Outstanding | 4.48% | 2.76% | -0.59% | -0.54% | -2.51% |
| Average Diluted Shares Outstanding | 4.48% | 2.76% | -0.59% | -0.54% | -2.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -1.02% | -0.99% | -0.12% | -0.59% |